Francesco Leonardi

Parma, 43100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Unraveling the Connection: Pancreatic Cancer Cells and Schwann Cells.

Unraveling the Connection: Pancreatic Cancer Cells and Schwann Cells.

Journal: Journal of clinical medicine

Published: February 27, 2024

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?

Journal: Life (Basel, Switzerland)

Published: September 28, 2023

A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists.

A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists.

Journal: Current oncology (Toronto, Ont.)

Published: September 19, 2023

Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study.

Association of hypothyroidism with survival in pancreatic cancer: retrospective cohort study.

Journal: BJS open

Published: April 28, 2023

Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity.

Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity.

Journal: Exploration of targeted anti-tumor therapy

Published: February 27, 2023

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis.

Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis.

Journal: Current oncology (Toronto, Ont.)

Published: December 03, 2022

Olaparib as a single agent treatment in pre-treated metastatic pancreatic cancer patient harboring BRCA2 mutation: What could we expect?

Olaparib as a single agent treatment in pre-treated metastatic pancreatic cancer patient harboring BRCA2 mutation: What could we expect?

Journal: Tumori

Published: October 27, 2022

Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.

Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.

Journal: Leukemia

Published: July 25, 2022

Should patients on levothyroxine therapy be screened for pancreatic cancer?

Should patients on levothyroxine therapy be screened for pancreatic cancer?

Journal: Acta bio-medica : Atenei Parmensis

Published: June 19, 2022

It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer.

It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer.

Journal: Life (Basel, Switzerland)

Published: May 13, 2022

Comment on "Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma by Crippa et al."

Comment on "Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma by Crippa et al."

Journal: Annals of surgery

Published: February 07, 2022

Three distinct outcomes in patients with colorectal adenocarcinoma and lymphovascular invasion: the good, the bad, and the ugly.

Three distinct outcomes in patients with colorectal adenocarcinoma and lymphovascular invasion: the good, the bad, and the ugly.

Journal: International journal of colorectal disease

Published: August 02, 2021

Showing 1-12 of 42

Last Updated: 09/26/2026